GT Newsletter | Competition Currents | July 2026

Short summary

This competition law newsletter rounds up recent U.S. and international antitrust developments, including a Colorado price cap on arthritis drugs being blocked, Express Scripts facing antitrust claims over pharmacy reimbursement practices, and DOJ action on Bayer's seed loyalty program. The content covers pharmaceutical, agricultural, and consumer goods litigation with no AI-specific relevance.

• •Colorado price cap on Enbrel blocked by federal judge over patent protections
• •Express Scripts faces antitrust suit over affiliate pharmacy reimbursement practices
• •DOJ secures commitments from Bayer CropScience to modify seed loyalty program

Generated with AI, which can make mistakes.